<DOC>
	<DOC>NCT01253226</DOC>
	<brief_summary>This study will evaluate the safety and tolerability of multiple doses of LY2127399 in Japanese patients with rheumatoid arthritis (RA).The study consists of a 20 week treatment period. All subjects will be followed up for 12 weeks after the last study drug administration.</brief_summary>
	<brief_title>A Study for Japanese Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Antibodies, Monoclonal</mesh_term>
	<criteria>Have given written informed consent Women must not be pregnant, breastfeeding or be at risk to become pregnant during study participation Diagnosis of Rheumatoid Arthritis Active Rheumatoid Arthritis Current, regular use of Methotrexate, at a stable dose Body weight between 40 and 105 kg, inclusive Use of excluded medications (reviewed by study doctor) Have medical findings which, in the opinion of the study doctor, put patient at an unacceptable risk for participation in the study Have had recent or ongoing infection which, in the opinion of the study doctor put patient at an unacceptable risk for participation Evidence of tuberculosis Have systemic inflammatory condition other than RA</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>